Re: you won’t see anyone buying this
in response to
by
posted on
Dec 06, 2023 12:05PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
"over the last 2 years alone. That means every royalty distribution will be more than 1/3 less forever."
every chance these folks get they have done nothing but line their pockets at the lowest possible levels available! We may all see a tiny piece of the pie but their making dam sure they feast on the majority of it! Crooked imo.